Economical and Expandable Diagnostic and Theranostic Imaging
Economical: The most cost-effective imaging platform with low entry cost and little operating and maintenance costs
Expandable: Upgradable at any time from Diagnostic CT to ultra-high-resolution molecular diagnostic and radiotherapy imaging
Essential: Expand your preclinical research with applications that most-likely never appeared on you radar screen
Easy-to-use: Master multi-modality acquisitions & reconstructions in one day
However, don’t take our word for it. Listen to what some of our users have to say:
Prof. Masayuki Inubushi, principal nuclear medicine investigator at the Kawasaki Medical University, and a Japanese opinion leader in molecular imaging states: “If we expect to see structures in a mouse that we are used to see in human imaging, we will need to achieve size-proportional anatomical and functional resolution. Today, such high resolution can only be achieved with MILabs U-SPECT/ CT systems”.
At the nuclear cardiology core facility of the CHFC-Würzburg: “The MILabs E-Class system enables us to eliminate many trade-offs associated with selecting either PET or SPECT imaging since the system is upgradable and both studies can be conducted simultaneously, at high spatiotemporal resolution” according to Prof. Dr. Takahiro Higuchi, Head of Pre-Clinical Imaging. “Moreover, by complementing PET and SPECT with a unique dual-gated low-dose CT design, the system offers an economical solution for our translational cardiology imaging research”.
Dr. Radu Mihai, Scientific Director of the Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering inBukarest, decided to complement the installation of a cyclotron with the addition of an MILabs PET/CT system. “Supported by European collaborators, we wanted to ensure that our new Interdisciplinary research for Romanian radio pharmaceuticals production used in medical diagnosis and therapy had the best chances for success. We discovered that MILabs’ E-Class PET/CT was the only affordable system with the required performance to translate our diagnostic and theranostic research into the clinic”.
Exclusive imaging design for diagnostic and theranostic applications
The use of targeted radiotherapy is forecasted to overtake diagnostic clinical applications by 2024, thus driving the rapidly growing need for preclinical imaging equipment with theranostic application capabilities. MILabs’ E-Class broadband photon tomography features the only technology proven for sub-mm imaging of virtually all isotopes with targeted radiotherapy potential including: Alpha emitters: 209At, 212Pb, 213Bi, 223Ra, 225Ac Beta emitters: 131I, 177Lu, 188Re Auger electron emitters: 125I, 123I, 195mPt, 124I